- Home
- KPRX vs SEED Comparison
KPRX vs SEED Comparison
Compare KPRX & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- SEED
- Stock Information
- Founded
- KPRX 1998
- SEED 1997
- Country
- KPRX United States
- SEED China
- Employees
- KPRX N/A
- SEED N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SEED Farming/Seeds/Milling
- Sector
- KPRX Health Care
- SEED Consumer Staples
- Exchange
- KPRX Nasdaq
- SEED Nasdaq
- Market Cap
- KPRX 9.1M
- SEED 10.7M
- IPO Year
- KPRX N/A
- SEED N/A
- Fundamental
- Price
- KPRX $3.08
- SEED $1.15
- Analyst Decision
- KPRX Strong Buy
- SEED
- Analyst Count
- KPRX 1
- SEED 0
- Target Price
- KPRX $10.00
- SEED N/A
- AVG Volume (30 Days)
- KPRX 1.3M
- SEED 15.7K
- Earning Date
- KPRX 05-09-2025
- SEED 06-17-2025
- Dividend Yield
- KPRX N/A
- SEED N/A
- EPS Growth
- KPRX N/A
- SEED N/A
- EPS
- KPRX N/A
- SEED 0.46
- Revenue
- KPRX $20,000.00
- SEED $16,163,803.00
- Revenue This Year
- KPRX N/A
- SEED N/A
- Revenue Next Year
- KPRX N/A
- SEED N/A
- P/E Ratio
- KPRX N/A
- SEED $2.52
- Revenue Growth
- KPRX N/A
- SEED 21.51
- 52 Week Low
- KPRX $2.51
- SEED $1.10
- 52 Week High
- KPRX $5.55
- SEED $5.59
- Technical
- Relative Strength Index (RSI)
- KPRX 48.79
- SEED 41.51
- Support Level
- KPRX $2.90
- SEED $1.12
- Resistance Level
- KPRX $4.18
- SEED $1.20
- Average True Range (ATR)
- KPRX 0.26
- SEED 0.05
- MACD
- KPRX 0.00
- SEED 0.01
- Stochastic Oscillator
- KPRX 19.12
- SEED 33.33
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.